European Journal of Surgical Oncology
Volume 34, Issue 12 , Pages 1293-1298 , December 2008

Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised

,Accepted 11 November 2007.

References 

  1. http://www.cancerscreening.nhs.uk/.
  2. Harvey JM, Sterrett GF, Frost FA. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis. Pathology. 2002;34:410–416
  3. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening, NHSBSP Publication No. 50. Sheffield: NHS Cancer Screening Programmes, June 2001.
  4. Lieske B, Ravichandran D, Wright D. Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma. Br J Cancer. 2006;95(1):62–66
  5. Lee AHS, Denley HE, Pinder SE, et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology. 2003;42:331–336
  6. Yeh I-T, Dimitrov D, Otto P, et al. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy: Correlation with excision specimen. Arch Pathol Lab Med. 2003;127:49–54
  7. Jackman RJ, Nowels KW, Rodriguez-Soto J, et al. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology. 1999;210(3):799–805
  8. Lin PH, Clyde JC, Bates DM, et al. Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia. Am J Surg. 1998;175:380–382
  9. Moore MM, Hargett CW, Hanks JB, et al. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg. 1997;225(6):726–731discussion 731–733
  10. Renshaw AA, Cartagena N, Schenkman RH, et al. Atypical ductal hyperplasia in breast core needle biopsies. Am J Clin Pathol. 2001;116:92–96
  11. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol. 1991;15(3):209–221
  12. Elston CW, Sloane JP, Amendoeira I, et al. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. Eur J Cancer. 2000;36:1769–1772
  13. Azavedo E, Svane G. Radial scars detected mammographically in a breast cancer screening programme. Eur J Radiol. 1992;15(1):18–21
  14. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology. 1993;23(3):225–231
  15. Patterson JA, Scott M, Anderson N, Kirk SJ. Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur J Surg Oncol. 2004;30(10):1065–1068
  16. Cawson JN, Malara F, Kavanagh A, et al. Fourteen-gauge needle core biopsy of mammographically evident radial scars. Is excision necessary?. Cancer. 2003;97(2):345–351
  17. Brenner RJ, Jackman RJ, Parker SH, et al. Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary?. AJR Am J Roentgenol. 2002;179(5):1179–1184
  18. Douglas-Jones AG, Denson JL, Cox AC, et al. Radial scar lesions of the breast diagnosed by needle core biopsy – analysis of cases containing occult malignancy. J Clin Pathol. 2007;60:295–298
  19. Brodie C, O'Doherty A, Quinn C. Fourteen-gauge needle core biopsy of mammographically evident radial scars: is excision necessary?. Cancer. 2004;100(3):652–653
  20. Liberman L. Clinical management issues in percutaneous core breast biopsy. Radiol Clin North Am. 2000;38(4):791–807Review
  21. Dmytrasz K, Tartter PI, Mizrachy H, et al. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J. 2003;9(1):10–12
  22. Irfan K, Brem RF. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy. Breast J. 2002;8(4):230–233
  23. O'Driscoll D, Britton P, Bobrow L, et al. Lobular carcinoma in situ on core biopsy – what is the clinical significance?. Clin Radiol. 2001;56(3):216–220
  24. Liberman L, Bracero N, Vuolo MA, et al. Percutaneous large-core biopsy of papillary lesions. AJR Am J Roentgenol. 1999;172:331–337
  25. Philpotts LE, Shaheen NA, Jain KS, et al. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical Importance. Radiology. 2000;216(3):831–837
  26. Mercado CL, Hamele-Bena D, Singer C, et al. Papillary lesions of the breast: evaluation with stereotactic directional vacuum-assisted biopsy. Radiology. 2001;221(3):650–655
  27. Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens. Am J Clin Pathol. 2004;122:217–221
  28. Gendler LS, Feldman SM, Balassanian R, et al. Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsy. Am J Surg. 2004;188:365–370
  29. Liberman L, Tornos C, Huzjan R, et al. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy?. AJR Am J Roentgenol. 2006;186:1328–1334
  30. Carder PJ, Garvican J, Haigh I, Liston JC. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast. Histopathology. 2005;46:320–327
  31. Page DL, Schuyler PA, Dupont WD, et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 2003;361:125–129
  32. Elsheik TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol. 2005;29(4):534–543
  33. Foster MC, Helvie MA, Gregory NE, et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?. Radiology. 2004;231(3):813–819
  34. Agoff SN, Lawton TJ. Papillary lesions of the breast with and without atypical ductal hyperplasia. Am J Clin Pathol. 2004;122:440–443
  35. Mercado CL, Hamele-Bena D, Oken SM, et al. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology. 2006;238(3):801–808
  36. Valdes EK, Tartter PI, Genelus-Dominique E, et al. Significance of papillary lesions at percutaneous breast biopsy. Ann Surg Oncol. 2006;13(4):480–482
  37. Fahrbach K, Sledge I, Cella C, et al. A comparison of the accuracy of two minimally invasive breast biopsy methods: a systematic literature review and meta-analysis. Arch Gynaecol Obstet. 2006;274:63–73
  38. Bedei L, Falcini F, Sanna PA, et al. Atypical ductal hyperplasia of the breast: the controversial management of a borderline lesion: experience of 47 cases diagnosed at vacuum-assisted biopsy. Breast. 2006;15(2):196–202
  39. Zhao L, Freimanis R, Bergman S, et al. Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities. Am Surg. 2003;69(9):757–762
  40. Allen S, Nayagam M, Pittam M, Ravichandran D, Wilkie J, Wright D. Audit of outcomes and indications for vacuum assisted breast biopsy. Eur J Surg Oncol. 2006;32(9):1036;(Abstract)

PII: S0748-7983(07)00610-5

doi: 10.1016/j.ejso.2007.11.005

European Journal of Surgical Oncology
Volume 34, Issue 12 , Pages 1293-1298 , December 2008

Article Tools